Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from 4DMedical Ltd ( (AU:4DX) ) is now available.
4DMedical Ltd has announced a new securities quotation with the issue of 4,251,548 fully paid ordinary shares, effective December 18, 2025. This expansion of securities highlights the company’s efforts to strengthen its capital base, which could bolster operational capabilities and further its market presence. This move is likely to advance the company’s growth strategy, create opportunities for stakeholders, and enhance its standing in the healthcare technology industry.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd operates in the healthcare technology sector, specializing in advanced imaging solutions. The company focuses on respiratory diagnostics and imaging innovations, providing healthcare professionals with tools to improve patient outcomes in pulmonary health and related areas.
Average Trading Volume: 5,143,817
Technical Sentiment Signal: Buy
Current Market Cap: A$1.55B
See more data about 4DX stock on TipRanks’ Stock Analysis page.